FEMaLe is in huge part about innovation and PrecisionLife is a major reason why.

They were recently named Analytics Company of the Year for ground-breaking AI and combinatorial analytics, transforming drug discovery and precision medicine .

“PrecisionLife is changing the way the world looks at predicting, preventing, and treating chronic diseases. Our proven, scalable, and unique AI and combinatorial analytics platforms generate more insights from patient data than anyone else on the planet, to advance understanding of disease biology and stratify patients at an unprecedented level of resolution. 
Understanding disease biology better enables our innovation engine to power patient-focused precision drug discovery and drive precision medicine for chronic diseases.
Together with our partners, we are delivering a new age of better, more personalized therapy options – improving health, for everyone.”

Read more about PrecisionLife in our Partners section here.